Quality by design (QbD) approach to match tablet glossiness.
Autorzy:
Mansuri N; Formulation Development, Piramal Pharma Solutions, Ahmedabad, India. Patel K; Formulation Development, Piramal Pharma Solutions, Ahmedabad, India. Mehta M; Formulation Development, Piramal Pharma Solutions, Ahmedabad, India. Vyas G; Formulation Development, Piramal Pharma Solutions, Ahmedabad, India. ReddyJP; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.; Gilead Sciences Inc., Foster City, CA, USA. Shah T; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA. Steinbach D; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA. Desai D; Drug Product Science and Technology, Bristol-Myers Squibb Company, New Brunswick, NJ, USA.
Parameter estimation for roller compaction process using an instrumented vector TF mini roller compactor.
Autorzy:
ReddyJP; Drug Product Science and Technology, Bristol-Myers Squibb , New Brunswick , NJ , USA. Phanse R; Drug Product Science and Technology, Bristol-Myers Squibb , New Brunswick , NJ , USA. Nesarikar V; Drug Product Science and Technology, Bristol-Myers Squibb , New Brunswick , NJ , USA.
ReddyJP; Department of Medical Retina, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India. Shanker PM; Department of Medical Retina, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India. Ganesan G; Department of Medical Retina, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India. Prabu R; Department of Medical Retina, Sankara Eye Hospital, Coimbatore, Tamil Nadu, India.
Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
Autorzy:
Bambhroliya A; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States of America.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Van Wyhe RD; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Baylor College of Medicine, Houston, TX, United States of America. Kumar S; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States of America.; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Debeb BG; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. ReddyJP; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Van Laere S; Department of Oncology, the University of Antwerp, Antwerpen, Belgium. El-Zein R; Department of Radiology, Houston Methodist Hospital, Houston, TX, United States of America. Rao A; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Woodward WA; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Department of Radiation Oncology, the University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Apr 04; Vol. 13 (4), pp. e0192689. Date of Electronic Publication: 2018 Apr 04 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.
Autorzy:
Ho JC; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Dabaja BS; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Milgrom SA; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Smith GL; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. ReddyJP; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Mazloom A; b Tacoma Valley Radiation Oncology , Tacoma , WA , USA. Young KH; c Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Deng L; c Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Medeiros LJ; c Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Dong W; d Department of Biostatistics , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Allen PK; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Andraos TY; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Fowler NH; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Nastoupil LJ; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Oki Y; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Fayad LE; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Turturro F; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Neelapu SS; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Westin J; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Hagemeister FB; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Rodriguez MA; e Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Pinnix CC; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Dec; Vol. 58 (12), pp. 2833-2844. Date of Electronic Publication: 2017 May 09.
Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.
Autorzy:
ReddyJP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Pettaway CA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Levy LB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Pagliaro LC; Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA. Tamboli P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Rao P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Jayaratna I; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Hoffman KE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2017 Apr; Vol. 119 (4), pp. 591-597. Date of Electronic Publication: 2016 Nov 08.
Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy.
Autorzy:
Akhtari M; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.; b Department of Radiation Oncology , The University of Texas Medical Branch at Galveston , Galveston , TX , USA. ReddyJP; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Pinnix CC; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Allen PK; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Osborne EM; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Gunther JR; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Milgrom SA; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Smith GL; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Wogan CF; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Fowler N; c Department of Lymphoma & Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Rodriguez MA; c Department of Lymphoma & Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. Dabaja B; a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (1), pp. 34-8. Date of Electronic Publication: 2015 May 12.
Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma.
Autorzy:
Youssef B; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Shank J; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . ReddyJP; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Pinnix CC; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Farha G; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Akhtari M; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .; Department of Radiation Oncology, The University of Texas Medical Branch at Galveston, Galveston, TX, USA. . Allen PK; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Fanale MA; Departments of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. . Garcia JA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Horace PH; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Milgrom S; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Smith GL; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Nieto Y; Departments of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. . Arzu I; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Wang H; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. . Fowler N; Departments of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. . Rodriguez MA; Departments of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. . Dabaja B; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. .
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
